Head and Neck Cancer News

• Divorce or Wait? 'Underinsurance' Forces Grave Decisions Misty Selph found herself with a rare metastatic cancer and an insurance plan that covered virtually none of the specialized care she required, forcing tough choices and delaying her care.
  Medscape Medical News, March 20, 2023
• Alert Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas The targeted therapy combination beat chemotherapy on progression-free survival, but there was no difference in overall survival at the interim analysis.
  Medscape Medical News, March 17, 2023
• How These First Responders Became Users of Grail's 50-Cancer Test In 2018, a cancer screening program began offering free advanced cancer screening to Arizona firefighters. By 2021, it became an early adopter of the Galleri test, running 1000s of the tests.
  Medscape Medical News, February 28, 2023
• Double Test for HPV in Head and Neck Cancer to Optimize Care Patients with head and neck cancer who have equivocal results on routine p16 assay for HPV should be tested again with a test that measures HPV DNA, say researchers.
  Medscape Medical News, February 23, 2023
• AI-Based Imaging Technology May Predict Lung Cancer Outcomes Big data and artificial intelligence could lead the way in future cancer research and clinical care.
  Medscape Medical News, February 23, 2023
• Lenvatinib May Up Survival in Anaplastic Thyroid Cancer Among patients with unresectable anaplastic thyroid cancer treated with lenvatinib, average survival was prolonged. The study was published as a preprint and has not yet been peer reviewed.
  First Look, February 22, 2023
• Maternal Infection in Pregnancy Ups Risk for Childhood Leukemia? Maternal urinary and genital tract infections during pregnancy appear to markedly increase the risk for leukemia in offspring, warn researchers in a large-scale analysis of Danish registry data.
  Medscape Medical News, February 20, 2023
• Blood Test Positive for Cancer, but Is There Really a Tumor? A cancer screening program in Arizona that offers the Galleri blood test to first responders provides some insight into how well the test can catch cancers in this high-risk group.
  Medscape Medical News, February 17, 2023
• Docetaxel as Alternative to Cisplatin for H&N Radiotherapy Investigators report the first phase 3 results for a radiosensitizing alternative to cisplatin for patients who cannot tolerate it.
  Medscape Medical News, February 14, 2023
• Ultraprocessed Food and Increased Risk of Cancer: UK Study Eating ultraprocessed foods appears to increase the risk of developing and dying from cancer, suggests an observational study from the UK, but experts urge caution in drawing firm conclusions.
  Medscape Medical News, February 02, 2023
• Novel HER2 Assay to Predict HER2+ Breast Cancer Tx Response An award-winning genomic assay for measuring HER2 mRNA expression could help predict treatment responses in advanced HER2+ breast cancer and ultimately guide clinical decision-making, suggests study.
  Medscape Medical News, January 25, 2023
• Hypofractionated Radiation Can Increase Pain in Laryngeal SCC Investigators urge clinicians to be mindful of this issue. The study was published as a preprint and has not yet been peer reviewed.
  First Look, January 23, 2023
• Ultralow Dose of Nivolumab Offers Huge Cost Savings A clinical trial from India raises the possibility of huge cost savings by using ultralow immunotherapy doses in the treatment of head and neck cancer.
  Medscape Medical News, January 18, 2023
• Renowned Stroke Expert Ralph Sacco, MD, Dies Sacco, the only physician to have served as president of both the American Heart Association (AHA) and American Academy of Neurology (AAN), was 65.
  Medscape Medical News, January 17, 2023
• Screen for Suicide Risk in Cancer Patients Undergoing Surgery? SEER data show a significantly increased risk for suicide among some patients who undergo cancer surgery, highlighting the need for distress screening and treatment.
  Medscape Medical News, January 13, 2023
• Promises and Pitfalls of Genetic Screening for Rare Thyroid Cancer Early surgery may benefit patients shown to be at risk for medullary thyroid cancer through genetic screening program, but overall merit of such gene testing remains debatable, say editorialists.
  Medscape Medical News, January 11, 2023
• Could Nodal RT Explain Failure of ICIs in Head and Neck Cancer? Immune checkpoint inhibitors (ICIs) have shown impressive efficacy in many different cancer types, but not in head and neck cancer: could nodal irradiation blunt the immune response?
  Medscape Medical News, January 10, 2023
• Vitamin D Relieved Toxic Erythema of Chemotherapy in Small Study Vitamin D – 50,000 IU for one patient and 100,000 IU for the others – was administered a mean of 4.3 days from rash onset and again in 7 days.
  MDedge News, January 06, 2023
• Extensive Resection Boosts Survival in Low-Grade Brain Tumor Patients with diffuse low-grade glioma should undergo early, extensive resection, urge researchers reporting survival benefits from this intervention.
  Medscape Medical News, January 06, 2023
• Genetic Test Identifies Parental Source of Cancer Variant A new test can determine whether an inherited disease gene variant came from a patient's mother or father.
  Medscape Medical News, December 30, 2022